Acetylcysteine Against Acute Renal Insult During Cardiopulmonary Bypass.

NCT00190034 · clinicaltrials.gov ↗

PHASE4

Phase

SUSPENDED

Status

60

Enrollment

OTHER

Sponsor class

Stopped opposite result

Conditions

Cardiovascular Disease
Renal Insufficiency, Acute
Cardiopulmonary Bypass

Interventions

DRUG: N-Acetylcysteine 600mg/tab

Sponsor

Far Eastern Memorial Hospital

Collaborators

[object Object]